<DOC>
	<DOCNO>NCT01738724</DOCNO>
	<brief_summary>The investigators´aim ass whether progestagen dienogest reduces leiomyoma volume associate symptom extent gonadotropin release hormone ( GnRH ) analogs progestagen desogestrel whether inferior drug already use .</brief_summary>
	<brief_title>Study Efficacy Dienogest Treatment Uterine Leiomyomas When Compared Desogestrel Goserelin</brief_title>
	<detailed_description>Uterine leiomyoma prevalent condition among woman , although mainly asymptomatic , may relate bothersome debilitating symptom , uterine bleeding pelvic pain pressure . The standard treatment surgical ( hysterectomy myomectomy ) , continue interest medical treatment . Progestagens long use control bleed associate leiomyoma , able decrease myoma volume . GnRH analogs well stablished agent , capable control symptom decrease tumors´volume , use limit bone loss menopausal symptom . A newly introduce progestagen , dienogest , study treat endometriosis , effect leiomyoma start assess . The investigator aim compare dienogest GnRH analog goserelin progestagen desogestrel randomize trial see new treatment compare previously use drug whether similar , inferior superior control leiomyoma associate symptom decrease leiomyoma volume .</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Goserelin</mesh_term>
	<mesh_term>Dienogest</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<mesh_term>Nandrolone</mesh_term>
	<criteria>Women 35 55 year age Uterine volume 50cc 500cc Abnormal uterine bleeding probably associate intramural uterine leiomyoma Pregnancy Liver kidney dysfunction Women submucosal subserosal uterine leiomyomas Women contraindication drug ( category 3 4 WHO eligibility criterion ) Use anticoagulant Others cause abnormal uterine bleeding ( endometrial pathology , cervical pathology )</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>